Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Post by K4LIFEEon Aug 01, 2018 7:07am

117 Views

Post# 28396150

Fourth quarter results : 17% revenue increase in Q, 81% YOY

Key Operating Highlights

Eleventh consecutive quarter of positive Adjusted EBITDA from ACMPR operations¹. $2.2 million in adjusted EBITDA from ACMPR operations¹ in the quarter and $8.4 million for the year, a 38% increase over the prior year.
Improved cash costs to produce dried cannabis per gram¹ ("Cash costs") to $0.95, a decrease of $0.01 in the quarter, remaining below $1.00 for the second consecutive quarter.
International operations and presence increased from Canada, US and Australia to also include Germany, Malta, Lesotho, Italy, Colombia, Argentina, United Kingdom and Uruguay. Subsequent to year-end, announced access to additional countries including Jamaica and Brazil in the fall.
Annual production capacity in Canada currently at 30,000 kgs at Aphria One and 5,000 kgs at Broken Coast.
Annual production capacity in Canada growing to 255,000 kgs, with first sale expected in January 2019, all expansions remain on time, pending Health Canada approval, and on budget.
Secured partnership with one of North America's largest liquor distributors, Southern Glazer's through their Canadian subsidiary, Great North Distributors, providing Aphria with an exclusive for cannabis representation²
Signed MOU's with British Columbia, Alberta, Manitoba, Quebec, New Brunswick and the Yukon Territory, with more agreements to be announced in the short-term.
Added significantly to our senior leadership team with the hire of our Chief Commercial Officer and Chief Legal Officer.
Continued leadership in cannabis product innovation with announcement of a major investment in our Extraction Centre of Excellence.